Platelet Inhibition to Target Reperfusion Injury: The PITRI Trial
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2018
Price : $35 *
At a glance
- Drugs Cangrelor (Primary)
- Indications Myocardial infarction
- Focus Proof of concept; Therapeutic Use
- Acronyms PITRI
- 17 Oct 2018 Planned primary completion date changed from 1 Feb 2020 to 1 Jul 2020.
- 17 Oct 2018 Status changed from not yet recruiting to recruiting.
- 10 Apr 2017 New trial record